Univar Inc. (UNVR) Given Average Recommendation of “Buy” by Analysts
Univar Inc. (NYSE:UNVR) has earned an average recommendation of “Buy” from the seven brokerages that are presently covering the stock. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $24.40.
UNVR has been the topic of a number of recent research reports. Zacks Investment Research lowered Univar from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 18th. Credit Suisse Group raised Univar from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $22.00 to $31.00 in a research note on Friday, December 9th. Finally, Wells Fargo & Company raised Univar from a “market perform” rating to an “outperform” rating in a research note on Thursday, December 15th.
TRADEMARK VIOLATION NOTICE: This article was first posted by Watch List News and is the propert of of Watch List News. If you are viewing this article on another site, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The legal version of this article can be viewed at http://www.watchlistnews.com/univar-inc-unvr-given-average-recommendation-of-buy-by-analysts/1061226.html.
Shares of Univar (NYSE:UNVR) opened at 28.77 on Monday. The company’s 50-day moving average price is $26.84 and its 200-day moving average price is $22.21. Univar has a 1-year low of $10.65 and a 1-year high of $28.98. The company’s market capitalization is $3.98 billion.
Univar (NYSE:UNVR) last announced its quarterly earnings results on Friday, November 4th. The company reported $0.17 EPS for the quarter, missing the Zacks’ consensus estimate of $0.20 by $0.03. Univar had a negative net margin of 0.15% and a positive return on equity of 8.52%. The firm had revenue of $2 billion for the quarter, compared to analyst estimates of $2.07 billion. Univar’s revenue for the quarter was down 90.9% compared to the same quarter last year. On average, equities analysts expect that Univar will post $0.67 earnings per share for the current fiscal year.
In other Univar news, insider Christopher Oversby sold 151,172 shares of the business’s stock in a transaction that occurred on Monday, December 19th. The stock was sold at an average price of $26.21, for a total value of $3,962,218.12. Following the transaction, the insider now directly owns 184,727 shares of the company’s stock, valued at $4,841,694.67. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Erik Viens sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 7th. The shares were sold at an average price of $26.44, for a total value of $52,880.00. Following the completion of the transaction, the senior vice president now directly owns 32,196 shares in the company, valued at $851,262.24. The disclosure for this sale can be found here. 2.49% of the stock is owned by corporate insiders.
A number of institutional investors have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD raised its position in shares of Univar by 29.2% in the third quarter. Price T Rowe Associates Inc. MD now owns 3,872,363 shares of the company’s stock valued at $84,611,000 after buying an additional 875,822 shares during the period. Bamco Inc. NY purchased a new stake in Univar during the third quarter valued at approximately $32,775,000. Jane Street Group LLC purchased a new stake in Univar during the third quarter valued at approximately $259,000. Scopus Asset Management L.P. purchased a new stake in Univar during the third quarter valued at approximately $2,185,000. Finally, Highbridge Capital Management LLC purchased a new stake in Univar during the third quarter valued at approximately $314,000. 97.31% of the stock is currently owned by hedge funds and other institutional investors.
Univar Inc is a distributor of commodity and specialty chemicals. The Company’s segments include Univar USA (USA); Univar Canada (Canada); Univar Europe, the Middle East and Africa (EMEA), and Rest of World. The Rest of World segment includes developing businesses in Latin America, including Brazil and Mexico, and the Asia-Pacific region.
Receive News & Ratings for Univar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.